Stay updated on Lorlatinib Combos in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib Combos in Lung Cancer Clinical Trial page.

Latest updates to the Lorlatinib Combos in Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record history now reflects the latest revision (v3.6.0) with Ibiayi Dagogo-Jack, M.D. as the responsible party and a Last verified timestamp; the previous verbiage including 'Last known status was: Verified' and author details was removed.SummaryDifference3%

- Check21 days agoChange DetectedA new latest revision entry, v3.5.5, has been added to the record history. The older revision entry v3.5.4 has been removed from the history display.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.5.4 was added and the previous revision v3.5.3 was removed. This change updates the page to reflect the latest revision of the study record history.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision, v3.5.3, was added to the history, replacing the previous v3.5.2. This updates the page's revision record to reflect the latest version.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded Revision: v3.5.2 to the record history; Deleted Revision: v3.5.0 from the record history.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded a new site revision entry (v3.5.0) and removed the previous revision (v3.4.3) in the Record History.SummaryDifference0.1%

Stay in the know with updates to Lorlatinib Combos in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib Combos in Lung Cancer Clinical Trial page.